CrowdStrike Stock Absolutely Hammered: Not Buying Today
CrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
This piece breaks down the core influences on market indices, from macro indicators to liquidity, helping you anticipate possible moves.
27,686 articlesCrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
RAD Intel launches a Reg A+ offering at $0.91 per share, pitching its AI-driven marketing platform to scale Fortune 1...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
SpaceX’s IPO filing reveals a company pivoting from rockets to AI infrastructure, with heavy spending and a long road...
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...
In May 2026, mainstream banks are quietly embracing tokenization as infrastructure, not ideology. Experts say crypto ...
CrowdStrike shares declined about 9% after a fiscal Q1 beat that failed to meet loftier expectations, triggering a br...
Shoppers are pouring money into immune-boosting supplements in 2026, with colostrum products among the hottest catego...
Anthropic filed confidentially for an IPO on June 1, 2026, signaling a landmark tech debut. For individual investors,...
Regulators across Africa are shifting from bans to licensing, turning crypto into key remittance rails and reshaping ...
As tech swings create headlines, a $34 ETF offering broad exposure with built in volatility controls rises as a safer...